NeuTigers Brings Edge Computing to COVID Detection

article image

NeuTigers’ miniaturized neural networks allow wearable point-of-care devices like wristwatches to collect and analyze data on the spot. The first application among many possible is a new screening method for COVID-19 infection.

It’s not unusual these days to see employees lined up in the lobby of their office building to have their temperature taken, one of the CDC’s recommended strategies for slowing the spread of the COVID-19 virus. But frankly, as a method of saying who has it and who doesn’t, a coin flip is probably just as accurate. Notes Gregory Nicola, MD, chief medical officer of medical artificial intelligence start-up NeuTigers Inc., “There is no scientific basis for thermal checks in a building,” and besides, the company’s research has shown that on-site temperature measurements are inaccurate for this purpose more than 50% of the time. The founders of NeuTigers believe they offer a much more accurate COVID screen in a wristwatch that uses neural networks to analyze many physiological parameters collected from the devices.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: